Skip to main content

Advertisement

SpringerLink
Log in

Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach

  • Letter to the Editor
  • Published:
Neuroradiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Silberstein SD, Young WB (1995) Safety and efficiency of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 45(3):577–584

    PubMed  CAS  Google Scholar 

  2. Lindboe CF, Dahl T, Rostad B (1989) Fatal stroke in migraine: a case report with autopsy findings. Cephalalgia 9(4):277–280

    Article  PubMed  CAS  Google Scholar 

  3. Salvesen R, Prytz JF (2000) Limb-threatening ischemia due to ergotamine: case report with angiographic evidence. Headache J Head Face Pain 40(4):320–323

    Article  CAS  Google Scholar 

  4. Stillman AE, Weinberg M, Mast WC, Palpant S (1977) Ischemic bowel disease attributable to ergot. Gastroenterology 72:1336–1337

    PubMed  CAS  Google Scholar 

  5. Schmidt R, Fanchamps A (1974) Effect of caffeine on intestinal absorption of ergotamine in man. Eur J Clin Pharmacol 7(3):213–216

    Article  PubMed  CAS  Google Scholar 

  6. Linton RAF, Band DM, Haire KM (1993) A new method of measuring cardiac output in man using lithium dilution. Br J Anaesth 71(2):262–266

    Article  PubMed  CAS  Google Scholar 

  7. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP (1982) Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11(3):337–343

    Article  PubMed  CAS  Google Scholar 

  8. Lee K, Lukovits T, Friedman J (2006) “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocritical Care 4(1):68–76

    Article  PubMed  Google Scholar 

  9. Millikan CH (1975) Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol 32(7):433–449

    Article  PubMed  CAS  Google Scholar 

  10. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR (1983) Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308(11):619–624

    Article  PubMed  CAS  Google Scholar 

  11. Tfelt-Hansen P, Ostergaard JR, Gøthgen I, Jacobsen E, Rasmussen JP, Husum B (1982) Nitroglycerin for ergotism. Eur J Clin Pharmacol 22(2):105–109

    Article  PubMed  CAS  Google Scholar 

  12. Goodson K, Lapointe M, Monroe T, Chalela J (2008) Intraventricular nicardipine forrefractory cerebral vasospasm after subarachnoid hemorrhage. Neurocritical Care 8(2):247–252

    Article  PubMed  CAS  Google Scholar 

  13. Haley EC, Kassell NF, Torner JC (1993) Randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. J Neurosurg 78(4):548–553

    Article  PubMed  Google Scholar 

  14. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T (2002) Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33(4):1011–1015

    Article  PubMed  CAS  Google Scholar 

  15. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K (1994) Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir 131(1):19–25

    Article  CAS  Google Scholar 

  16. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA (2004) Experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25(5):819–826

    PubMed  Google Scholar 

  17. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR (1989) Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 71(5):654–660

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Megan Miller MD & Avinash B. Kumar MD, FCCP

  2. Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Charles R. Callison MD

  3. Department of Radiology, Interventional Neuroradiology Division, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Charles R. Callison MD

  4. Department of Anesthesiology, Critical Care Division, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, IA, 52242, USA

    Avinash B. Kumar MD, FCCP

Authors
  1. Megan Miller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Avinash B. Kumar MD, FCCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles R. Callison MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Avinash B. Kumar MD, FCCP.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, M., Kumar, A.B. & Callison, C.R. Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach. Neuroradiology 54, 77–79 (2012). https://doi.org/10.1007/s00234-011-0859-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-011-0859-x

Keywords

Search

Navigation